For pharmaceutical companies navigating the complex transition from clinical research to commercial launch, the selection of service providers—ranging from distribution…
Read More
Navigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial Success
The pharmaceutical industry is witnessing a significant evolution in oral solid dosage (OSD) development, driven by an increasing demand for…
Read More
Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach
Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…
Read More
The UK Must Supercharge Its Commercial Strategy to Boost Global Life Sciences Competitiveness
Off the northwestern coast of mainland Europe, an island nation with significant ambitions for its life sciences sector is navigating…
Read More
Europe’s Biopharmaceutical Competitiveness and Commercial Strategies Under Scrutiny at BIO Europe Spring
Lisbon, Portugal – As the vibrant city of Lisbon recently concluded its tenure as host for the annual BIO Europe…
Read More
